|
首頁 > 美迪醫訊 > Carbapenem antimicrobial drugs Report |
Carbapenem antimicrobial drugs Report 【?2008-07-21 發布?】 美迪醫訊
Carbapenem antimicrobial drugs ReportResearch Report on Chinese Carbapenem antimicrobial drugs Market
Research Report on Chinese Carbapenem antimicrobial drugs Market
Price: US$1,900
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-68588305
E-mail: hhuang@medicexchange.com
The peport presents China's market status and development trend of Carbapenems,a class of beta-lactam antibiotics with broad antibacterial spectrum and strong antibacterial action。The report describes the status and development trend about Research & Development and sales of Carbapenems within global market,the China's current market scale and growth trend of Carbapenems in the next 5 years,comparison of domestic prodcut's market share and import product's。 At last the report summarizes the information of international Research & Development for new Carbapenems,the status of application and approval for Carbapenems reviewed by SFDA。
The data presented in this report can reflect the real market status in China,the China's market scale of Carbapenems grew from 230 million in 2000 to 680 million in 2005。
Table of Contents
Table of Contents
Abstract…………………………………………………………………………………1
Overview of products 3
1 General situation of international market of carbapenem
antibiotics……………………………………………………………………………4
2 Carbapenem drugs market in China 6
2.1 National market scale and growth trend from 2000 to 2005……6
2.2 Shares and variation trend of national carbapenem drugs from
2000 to 2005…………………………………………………………………………9
2.3 Sale volume and growth trend of Imipenem/Cilastatinfrom 2000
to 2005………………………………………………………………………………10
2.4 Sale volume and growth trend of Meropenem from 2000 to
2005……………………………………………………………………………………11
2.5 Sale volume and growth trend of Panipenem/Betamipron from
2000 to 2005…………………………………………………………………………11
2.6 Sales Status of Import and Domestic Carbapenem Drugs…………12
2.7 Evaluation on demand volume of carbapenem Bulk Drugs in the
next 5 years…………………………………………………………………………13
3. Shares of brands…………………………………………………………………15
3.1 Market share variation and advantage appraisal of the 5 brands
from 2000 to 2005…………………………………………………………………15
3.1.1 Market share variation of the 5 brands in recent 5 years…15
3.1.2 Shares of brands in 2005……………………………………………17
3.1.3 Sales Analysis on Different Brand Names of Meropenem from
2000 to 2004…………………………………………………………………………17
3.2 Market Shares of Different Brand Names in Sample Cities in
2005……………………………………………………………………………………19
“Tienam”……………………………………………………………………20
“BeiNeng”……………………………………………………………………21
“Mepem”………………………………………………………………………21
“Carbenin”…………………………………………………………………23
“Hisunpharm MeiTe”………………………………………………………23
3.3 Market Shares of Different Brand Names in Major Cities in
2005……………………………………………………………………………………24
Beijing…………………………………………………………………………24
Shanghai………………………………………………………………………25
Guangzhou………………………………………………………………………26
4. Research and Development of new products………………………………27
4.1 Domestic and imported products on Chinese market………………27
4.2 Imitation and Application Status of Carbapenem Antimicrobial
Drugs in China………………………………………………………………………29
4.2.1 Types of products……………………………………………………29
4.2.2 Application Enterprises……………………………………………31
4.3 Background of other carbapenem drugs about to enter into
Chinese market………………………………………………………………………38
Biapenem………………………………………………………………………38
Ertapenem……………………………………………………………………38
Doripenem……………………………………………………………………39
4.4 Penems products: comparison between Faropenem and
carbapenems…………………………………………………………………………39
4.5 Clinical evaluation of anti-severe infection drugs…………41
4.5.1 Main characters of carbapenem antibiotics…………………41
4.5.2 Clinical evaluation of carbapenems…………………………42
4.6 Products in process of development in the world currently…45
Appendix 1 List of Enterprises Submited Applications for
Carbapenems to SFDA………………………………………………………………47
Appendix 2 Retail Prices of Different Carbapenems with Different
Strengths……………………………………………………………………………59
Tables and Figures
Table 1 Launched Kinds of Carbapenems within the Global Market……4
Table 2 Sales Values of Carbapenems within the Global Market from
2000 to 2004…………………………………………………………………………5
Table 3 Breeds in the Catalogue of Drugs for Basic National Medical
Insurance………………………………………………………………………………6
Table 4 Market Scale of Carbapenems in China from 2000 to 2005……7
Table 5 Sales Scales of Three Carbapenems in 2005………………………9
Table 6 Sales Values of Imipenem/Cilastatin from 2000 to 2005……10
Table 7 Sales Values of Meropenem from 2000 to 2005……………………11
Table 8 Sales Values of Panipenem/Betamipron from 2001 to 2005……11
Table 9 Import Volumes of “TIENAM”(Imipenem/Cilastatin) from 2002
to 2005………………………………………………………………………………12
Table 10 Import Volumes of “Mepem”(Meropenem) from 2002 to first
half of 2005…………………………………………………………………………13
Table 11 Import Volumes of “Carbenin”(
本文關鍵字:
《美迪醫訊》歡迎您參與新聞投稿,業務咨詢: 美迪醫療網業務咨詢
《上海醫療器械批發》產品推薦
|
合作支持:中華醫學會 | 中華醫院管理學會 | 國家食品藥品監督管理家用護理器械商城 | 國藥勵展展覽有限責任公 | 醫學裝備協會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關于美迪 | 法律聲明 | 隱私保護 | 網站地圖 |
把美迪網放進收藏夾 把美迪醫療網介紹給我的朋友 給美迪醫療網留言
美迪醫療網廣告業務聯系:021-51601230 產品咨詢業務聯系:021-51601230 傳真:021-56532303 美迪醫療網業務咨詢 互聯網藥品信息服務許可證:(滬)-經營性-2009-0003 中華人民共和國電信與信息服務業務經營許可證:(滬)B2-20090029 滬ICP備14001091號-8 公安備案號 31010602000199 醫療器械經營許可證: 滬靜藥監械經營許20210003號 第二類醫療器械經營備案憑證: 滬靜藥監械經營備20220042號 營業執照:統一社會信用代碼91310108676284138X互聯網藥品信息服務資格書:(滬)-非經營性-2023-0081 |